The impact of COVID-19 has started to trickle into the sphere of conferences and large events.
Saskia v. Popescu
Advertisement
Saskia v. Popescu, PhD, MPH, MA, CIC, is a hospital epidemiologist and infection preventionist. During her work as an infection preventionist, she performed surveillance for infectious diseases, preparedness, and Ebola-response practices. She holds a doctorate in Biodefense from George Mason University where her research focuses on the role of infection prevention in facilitating global health security efforts. She is certified in Infection Control and has worked in both pediatric and adult acute care facilities.
Articles by Saskia v. Popescu
Can we avoid ESBL-E without contact precautions?
What can we learn from those who met PUI criteria?
Studies have shown that human coronaviruses can survive for days on certain surfaces. What does this mean for infection prevention efforts?
In a scenario where health care preparedness is key, what are the best strategies for US hospitals to pursue?
Does employing the universal use of gloves and gowns decrease the acquisition of antibiotic-resistant gram-negative bacteria?
New research on this resistant organism provides insight on what clinicians may need to account for.
A significant relationship exists between environmental exposures and colonization.
Infection preventionist Saskia Popescu discusses several rapid developments that have been released in this outbreak.
A new study is shedding light on how bioburden and patient colonization play off each other.
A study sheds light on the challenges we need to account for in treating neglected tropical diseases.
How many nursing homes have these microbes?
What is happening in Samoa’s fight against the vaccine-preventable disease?
Improving diagnostics needs a culture change.
Ebola vaccines could be given as an emergency intervention to individuals exposed to the virus.
A new study shows that patients with medical devices were more likely to have resistant infections.
Using genome sequencing could be a game-changer in tracing colonization related to health care-associated outbreaks.
An analysis of outbreaks shows some helpful trends in toxoplasmosis prevention.
The CDC’s latest report highlights higher rates of infections in the US, but this week let's focus on awareness so we can combat the threat of resistance.
From an infection prevention perspective, the nature of Acinetobacter baumannii makes it an organism on the radar for prevention efforts against health care-associated infections.
A new study sheds light on how Pseudomonas aeruginosa might pick up resistance to phage therapy.
Since 2014 NYC Health + Hospitals has worked to maintain preparedness against diseases like Ebola.
Assessing 195 countries’ capability to prepare, detect, and respond to outbreaks has found some major gaps.
Researchers stumbled upon a resistant mutation in group A Streptococcus that confers reduced susceptibility to β-lactam antibiotics.
What hurdles are companies facing in the pursuit of developing new antibiotics against multidrug-resistant organisms?
A new study points to an increased risk for infections in patients with PTSD.
The ECDC 2019 plan to address multi- and extensively-drug resistant gonorrhea has been released.
A patient was evaluated for Ebola in a Swedish hospital. Here's what we should take away from it.
Candidemia is the fourth most common health care-associated infection. To improve hospitalized patients’ safety, infectious disease physicians should be consulted.
Health officials provide 4 strategies to improve C auris surveillance efforts.
Advertisement
Advertisement
Advertisement
